WNT受体ROR2通过AKT激活驱动多发性骨髓瘤细胞与微环境相互作用
该研究通过无偏倚评估发现多发性骨髓瘤细胞高表达WNT非经典通路受体ROR2,其配体WNT5A在患者骨髓中丰度最高。ROR2介导骨髓瘤细胞与骨髓微环境黏附,敲低ROR2导致体内模型骨髓瘤细胞脱离龛位并凋亡,延缓疾病进展。ROR2过表达主要 deregulate PI3K/AKT和mTOR通路,临床已用的PI3K抑制剂可减少骨髓瘤细胞黏附。
要点
- ROR2在多发性骨髓瘤细胞中高表达,其配体WNT5A在患者骨髓中丰度最高。
- 敲低ROR2导致体内模型骨髓瘤细胞脱离龛位、凋亡并显著延缓疾病进展。
- ROR2过表达主要 deregulate PI3K/AKT和mTOR通路,临床PI3K抑制剂可减少骨髓瘤细胞黏附。
核心结论
- ROR2及其下游靶点可能为ROR2过表达的多发性骨髓瘤患者亚群提供新的治疗策略。
研究设计与样本
- 研究采用无偏倚评估受体酪氨酸激酶、体外和离体3D培养系统、体内模型及基因组学研究。
主要发现
- ROR2在多发性骨髓瘤细胞中高表达,其配体WNT5A是患者骨髓中最丰富的生长因子。
- 敲低ROR2导致体内模型骨髓瘤细胞脱离龛位,触发凋亡并显著延缓疾病进展。
- ROR2在癌细胞与微环境黏附中起关键作用。
- 基因组研究显示ROR2过表达主要 deregulate PI3K/AKT和mTOR通路。
- 临床已用的特异性PI3K抑制剂处理细胞可减少骨髓瘤细胞与骨髓的黏附。
临床怎么用
- ROR2及其下游靶点可能成为ROR2过表达的多发性骨髓瘤患者亚群的新治疗策略。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple myeloma is the second most frequent hematological cancer after lymphoma and remains an incurable disease. The pervasive support provided by the bone marrow microenvironment to myeloma cells is crucial for their survival. Here, an unbiased assessment of receptor tyrosine kinases overexpressed in myeloma identified ROR2, a receptor for the WNT noncanonical pathway, as highly expressed in myeloma cells. Its ligand, WNT5A is the most abundant growth factor in the bone marrow of myeloma patients. ROR2 mediates myeloma cells interactions with the surrounding bone marrow and its depletion resulted in detachment of myeloma cells from their niche in an in vivo model, triggering apoptosis and thus markedly delaying disease progression. Using in vitro and ex vivo 3D-culture systems, ROR2 was shown to exert a pivotal role in the adhesion of cancer cells to the microenvironment. Genomic studies revealed that the pathways mostly deregulated by ROR2 overexpression were PI3K/AKT and mTOR. Treatment of cells with specific PI3K inhibitors already used in the clinic reduced myeloma cell adhesion to the bone marrow. Together, our findings support the view that ROR2 and its downstream targets represent a novel therapeutic strategy for the large subgroup of MM patients whose cancer cells show ROR2 overexpression.
引用
- Frenquelli M, Caridi N, Antonini E, et al. The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation. Leukemia. 2019. PMID: 31148590. doi:10.1038/s41375-019-0486-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。